We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Stay up to date on the topics that matter to you

Liquid Biopsies

This page provides educational resources, events, news and products related to liquid biopsies. Content will cover aspects from advances in early cancer diagnosis and response to treatment, to their use alongside traditional biopsy techniques.

Liquid Biopsies – Highlights

The stages of metastasis.

Circulating Tumor Cells: Detection and Applications

In this article we explore circulating tumor cells (CTCs) asking what they are, why they are so valuable and how they are being used in modern oncology.

Recent Advances in Liquid Biopsy for Cancer

Liquid biopsies for cancer search for evidence of disease biomarkers, the most common of which include circulating tumor cells, cell-free nucleic acids, exosomes, proteins and phosphoproteins. Read on for insights on advances in the field that could revolutionize clinical oncology practice.

Liquid Biopsies in Cancer

Download this infographic to explore what liquid biopsies can tell us, how they compare to traditional surgical biopsies, and challenges in their development.

What Is cfDNA?

In this article, we will define what circulating free DNA are and how these biomarkers are analyzed in the clinic.

Liquid Biopsies

This infographic takes a look at some of the benefits that liquid biopsies can offer and explores examples of recent developments in this field.

Liquid Biopsies – News and Features

Artificial Intelligence Predicts Treatment Outcome in Ovarian Cancer Patients

A model based on artificial intelligence is able to predict the therapy outcome in 80% of ovarian cancer patients. The tool, named IRON (Integrated Radiogenomics for Ovarian Neoadjuvant therapy), analyzes various patient clinical features.

Answers to Unsolved Rare Disease Mysteries May Be on the Horizon

In this opinion piece, Neil Ward explores how advances in sequencing could help to provide new insights for rare disease patients.

Liquid Biopsy Improves Cancer Detection in Li-Fraumeni Syndrome Patients

A liquid biopsy that identifies cell-free DNA as a marker of cancer could improve cancer detection in patients with Li-Fraumeni syndrome, which carries an almost 100 percent lifetime risk of developing cancer.

Diabetes Can Age the Eye by 30 Years, Finds Protein Study

A team of scientists at Stanford University has taken a look inside the human eye with a new level of detail by using cutting-edge molecular analysis.

Association for Molecular Pathology Publishes Best Practice Recommendations for Liquid Biopsy Assay Validations

The Association for Molecular Pathology has published a set of 13 best practice recommendations for validating and reporting clinical circulating tumor DNA or liquid biopsy assays and their related scientific publications.

New Blood Test Detects Early-Stage Ovarian Cancer

A new study on human tissue and plasma shows the blood test may distinguish between cancerous and benign pelvic masses with up to 91% accuracy, surpassing other commercially available tests.

Liquid Biopsies – Multimedia

Cells

Automated Cell Selection and Retrieval Opens a Universe of Possibilities

Liquid Biopsy

Refining Liquid Biopsy: Generating More Information From Cell Free DNA

Revealing the Combinatorial Power of Genetic and Epigenetic Information for Early Cancer Detection content piece image

Revealing the Combinatorial Power of Genetic and Epigenetic Information for Early Cancer Detection

Liquid Biopsies – Webinars and Online Events

Harnessing the Power of ddPCR to Advance Precision Oncology

Harnessing the Power of ddPCR to Advance Precision Oncology

The Most Comprehensive Insights in Cancer Genomes: Translational Research content piece image

The Most Comprehensive Insights in Cancer Genomes: Translational Research

Gain Insights Into Therapeutic Resistance With Single Cell RNA-Seq content piece image

Gain Insights Into Therapeutic Resistance With Single Cell RNA-Seq

Related Products

DNA bases.

Beckman Coulter Life Sciences and Pillar Biosciences Announce NGS Application Development Pipeline

Oxford Nanopore Meets Apple’s M3 Silicon Chip

Sebia Launches M-InSight®, a Test for Monitoring Multiple Myeloma Patients

Yourgene Health Launches MagBench Automated DNA Extraction Instrument and Kit for NIPT Workflows

CareDx’s HeartCare Multimodality Service Receives Medicare Coverage for Heart Transplant Surveillance

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter